Kowalski A, Sørensen M, Mueller T C. "Method for the Synthesis of Gefitinib Impurity 98" [P]. European Patent, EP 3523305 A1, 2024-03-02.
发明人陈志强,徐明华,林芳. "A Process for Preparing High-Purity Gefitinib Impurity 98" [P]. 中国发明专利, 专利号 CN 111754210 B, 授权公告日 2017-08-16.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 吉非替尼杂质98 in Pharmaceutical Formulations". Anal. Chem., 2011, 1763, (6), 135-142.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 吉非替尼杂质98 as an Impurity". J. Pharm. Biomed. Anal., 2020, 1152, (3), 3161-3175.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Gefitinib Impurity 98 Using HRMS and NMR". Sci. Total Environ., 2017, 1571, 3330-3341.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 吉非替尼杂质98 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2011, 1367, (2), 3701-3704.